retatrutide safety trial results VisualAbstract: reduces body weight by 17.5% in patients with obesity Lilly's 'triple G' agonist triumphs

Its better at tightening than lifting, so any fat must first be removed, and there are people with a level of sagging that this style of treatment simply wont be able to do much for: those with heavy skin and severe sagging

105 , S117S314 (2024)

A new review explores how GLP-1 receptor agonists may blunt alcohol and drug reward signals, opening a promising but still unproven path toward repurposed treatments for addiction

Step back and the whole vetting process comes down to a single shift in posture: stop reading labels as promises and start reading them as claims to be checked

I did muay Thai for about two and a half years, and then when I got really into my studies, I stopped doing it